Pogátsa G, Koltai M Z, Balkányi I, Dévai J, Kiss V
Eur J Clin Pharmacol. 1985;28(4):367-70. doi: 10.1007/BF00544351.
In diabetic patients it has been shown that tolbutamide and carbutamide enhanced and glibenclamide did not influence the incidence of digitalis intoxication, or that of multifocal ectopic beats or coupling due to premature ectopic ventricular beats during digitalis therapy. In rabbits glibenclamide decreased and tolbutamide and carbutamide increased strophanthidin toxicity in a dose dependent manner. It was concluded that glibenclamide should be preferred to tolbutamide or carbutamide in digitalis-treated diabetics, when satisfactorily metabolic control is not achieved with a dietary regime alone.
在糖尿病患者中,已表明甲苯磺丁脲和氨磺丁脲会增加洋地黄中毒的发生率,而格列本脲则不会影响洋地黄中毒的发生率,也不会影响洋地黄治疗期间多源性异位搏动或室性早搏引起的联律的发生率。在兔子中,格列本脲以剂量依赖性方式降低毒毛花苷原的毒性,而甲苯磺丁脲和氨磺丁脲则增加其毒性。得出的结论是,在单独通过饮食疗法无法实现令人满意的代谢控制的情况下,对于接受洋地黄治疗的糖尿病患者,格列本脲应优于甲苯磺丁脲或氨磺丁脲。